Clinical Trial Update: Benralizumab Effect on Severe Chronic Rhinosinusitis With Eosinophilic Polyposis [Phase 2]

View source ↗

Summary

Phase 2 trial updating benralizumab’s effect on severe chronic rhinosinusitis with eosinophilic polyposis; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasal Polyps
• Rhinosinusitis

Drugs mentioned

• Benralizumab (benralizumab)

Snippet

Sponsor: Johns Hopkins University | Conditions: Chronic Rhinosinusitis (Diagnosis), Nasal Polyps | Phase 2 | Status: COMPLETED | Results posted: 2021-01-22